Navigation Links
Mentice, Inc. Announces Appointment of Vice-President, Sales and Marketing, Americas
Date:3/26/2008

EVANSTON, Ill., March 26 /PRNewswire/ -- Mentice, Inc. (a wholly owned subsidiary of Mentice AB, Gothenberg, Sweden), a leading supplier of virtual reality based training applications within the field of medicine has recently appointed Tim Shannon as Vice-President of Sales and Marketing, Americas.

Mr. Shannon brings to Mentice over 20 years of sales, sales management and marketing experience within the areas of Healthcare and Life Science. He has worldwide experience in a variety of high-level roles within the areas of interventional cardiology/radiology implantable devices, surgical devices and diagnostic cardiology imaging equipment and networking.

Prior to joining Mentice, Mr. Shannon held leadership positions at GE Healthcare, Datascope Corp. and VisualSonics Inc. His sales background includes Bristol-Myers, GE Healthcare, U.S. Surgical Corp., Boston Scientific Corp. and Datascope Corp.

Mr. Shannon will be tasked with growing the market for medical simulation throughout the Americas and establishing an operational infrastructure to support its growth.

"I am excited to join Mentice at such a pivotal time. Mentice has recently renewed its commitment to be the leader in the medical simulation market. It is my goal to further the significance of medical simulation throughout the Americas by continuing to position simulation as an integral part of physician training within the industrial and academic markets. In addition, I want to continue to strengthen that position via strategic alliances with our customers and through potential collaborative efforts with other companies within the marketplace," says Mr. Shannon.

About Mentice:

Mentice is a leader in medical simulation with approximately 600 installations worldwide, 100 validation studies and more than 30 issued and pending patents. Mentice's Family of Procedicus(TM) simulators focus on the area of minimally invasive surgery within the fields of endovascular intervention, core skills training, laparoscopy and arthroscopy training.

Website info: http://www.mentice.com

For more information contact:

Tim Shannon, Mentice Inc. U.S. office

1-877-MENTICE or email usinfo@mentice.com or tim.shannon@mentice.com


'/>"/>
SOURCE Mentice, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Webcast Alert: Lifeway Foods, Inc. Announces 2007 Year End Full Financial Results
2. Correction: Evalve Announces CE Mark Approval of the Worlds First Percutaneous Valve Repair System
3. North American Insurance Leaders, Inc. Announces Results of the Annual Meeting of Stockholders
4. China Medicine Announces Conference Call to Discuss Fourth Quarter and Fiscal Year 2007 Results
5. International Eye Foundation Announces Partnership with Newport Creative Communications
6. AcroMetrix Announces Launch of First Liquid MRSA Positive Control
7. Evalve Announces CE Mark Approval of the Worlds First Percutaneous Valve Repair System
8. Laerdal Medical Announces Strategic Relationship
9. Almost Family Announces Acquisition of Apex Home Health
10. Methodist Healthcare - Memphis Hospitals Announces the Extension of Tender Offers
11. MarketResearch.com Announces Distribution of Wireless Healthcare Research
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/23/2017)... ... March 23, 2017 , ... The ... from the NCQA. The accreditation covers StayWell’s asthma, coronary artery disease, congestive heart ... granted to organizations that have excellent programs for the delivery and improvement of ...
(Date:3/23/2017)... ... March 23, 2017 , ... March 23, 2017 - ... to easily reprint customer invoices, bills, statements and other correspondence when they have ... needed to retrieve and print the documents and batch them for efficient handling. ...
(Date:3/23/2017)... OR (PRWEB) , ... March 23, 2017 , ... Sharon ... Water, Global Climate Change and Your Health on VoiceAmerica, recently talked on her program ... she also used the occasion to remind listeners of an important distinction. World Water ...
(Date:3/23/2017)... ... March 23, 2017 , ... Corra Group is ... competitive pricing. Verisys through its FACIS and other services maintains the ... actions. , “We are delighted to be able to offer these various products ...
(Date:3/23/2017)... ... March 23, 2017 , ... ... New MEDDEV 2.7/1 Rev. 4 Guidance, **An FDAnews Webinar**, April 4, 2017 ... will the new EU MDR language change the way manufacturers approach CERs? ...
Breaking Medicine News(10 mins):
(Date:3/23/2017)... 23, 2017  Cornerstone Pharmaceuticals, Inc., a ... milestone today.  Following successful End-of-Phase I (EOP1) ... and Drug Administration (FDA), the Company has ... path forward to conduct pivotal trials of ... acute myeloid leukemia (AML) and pancreatic cancer. ...
(Date:3/23/2017)... March 23, 2017 Piramal ... Limited, anuncia el nombramiento de Stuart E. ... plataforma de servicios integrados completa para su base ... cargo clave en el crecimiento y ejecución de ... responsable de impulsar todas las actividades de desarrollo ...
(Date:3/23/2017)... Merrimack Pharmaceuticals, Inc. (NASDAQ: MACK ) ... a Phase 1 study of MM-310 in solid tumors. ... novel taxane and targets the EphA2 receptor, a protein ... major tumor types, including prostate, ovarian, bladder, gastric, pancreatic ... study is an important step in evaluating MM-310,s safety ...
Breaking Medicine Technology: